Why is Colinz Labs falling/rising?

As of 03-Sep, Colinz Laboratories Ltd is experiencing a decline in its stock price, currently at Rs 41.22, which represents a decrease of 2.16 (-4.98%). Today's price summary indicates that the stock opened with a gain of 3.71% but has since fallen to a day's low of Rs 41.22. The stock has underperformed its sector by 6.22% today and has seen a trend reversal after three consecutive days of gains. Over the past week, the stock has increased by 1.58%, but it has a negative return of 5.31% over the last month and a significant decline of 40.91% year-to-date. The company's weak long-term fundamentals, including a -1.90% CAGR growth in net sales over the last five years and a low return on equity of 4.71%, contribute to its current price movement. Additionally, the stock's poor EBIT to interest ratio of 0.37 raises concerns about its ability to service debt, further impacting investor confidence.
Broader market context shows that while the Sensex has experienced a slight decline of 0.27% over the past week, Colinz Laboratories has outperformed this benchmark in the same period. However, the stock has underperformed the broader market indices over the longer term, with a return of -27.63% in the past year compared to a -2.41% decline in the Sensex. This underperformance, coupled with falling investor participation and a significant drop in delivery volume, suggests a lack of confidence among investors. The stock's current valuation is considered expensive relative to its peers, and its flat results in recent quarters further exacerbate the negative sentiment surrounding it.